Immunocore's Series A Round

Immunocore raised a round of funding on July 16, 2015.

Immunocore is a biotechnology company, with a highly innovative immuno-oncology platform technology called ImmTACs. ImmTACs are a novel class of biologic drugs based on the Company's proprietary T cel…

Articles about Immunocore's Series A Round: